Mice from six genetically distinct strains were examined for their immune responses to Candida albicans in in vitro and in vivo assays, and naive mice and mice immunized with the fungus were challenged intravenously with three different doses of C. albicans to determine differences in susceptibility. Naive mice from the six groups showed substantial differences in resistance to challenge based on mortalities and quantitative cultures of kidneys, with mice from strains C57BL/6J and BALB/cByJ showing the most resistance; mice from strains A/J, C3H/HeJ, and CBA/J showing moderate susceptibility; and mice from strain DBA/2J showing the highest degree of susceptibility to challenge. Unimmunized mice from strains C57BL/6J and BALB/cByJ did not produce detectable levels of Candida-specific antibody by the end of the 28-day observation period when challenged intravenously, but the other strains did. Immunized mice showed a degree of protection to challenge, with all groups except mice from strain BALB/cByJ showing a reduction of two to three log units in the level of colonization in their kidneys and all strains producing significant levels of antibody. Additionally, the immunized mice of all strains developed substantial levels of delayed-type hypersensitivity and demonstrated nearly identical lymphocyte proliferative responses to Candida antigens. The results indicate that resistance to systemic candidiasis is dependent upon a combination of innate factors, predominately an intact complement system, and the acquisition of an immune response, most likely of a cell-mediated type. Additionally, the findings suggest that genetic control of acquired resistance to C. albicans may not be associated with the H-2 complex.
Demonstration in the laboratory of the precise mechanisms of resistance, either innate or acquired, to disease caused by Candida albicans has met with only limited success. Innately, polymorphonuclear leukocytes (PMN) are clearly one of the first lines of defense (18, 19, 41) , and complement has been demonstrated to play a major role by acting as an opsonin for phagocytosis by this cell type (16, 24, 25) . The role of macrophages is much less clear, as studies with agents known to stimulate macrophages have provided conflicting results (14, 22, 37, 46) . Studies in our laboratory in the past have been oriented predominately toward the mechanism(s) of acquired immunity rather than the innate response. Using T-cell-depleted mice (11) and mice treated with cyclophosphamide (28), we obtained data which implicated the T-lymphocyte in immunity, but its precise involvement, e.g., at the level of cell-mediated immunity or in a helper function in antibody formation, was not determined. Furthermore, data published by others attempting to transfer protection, either with cell suspensions (13, 23, 32, 40) or serum (17, 29, 32) , to demonstrate the nature of acquired immunity are conflicting and less than convincing in many cases. Our own unpublished transfer studies with cells from the spleen, lymph node, or peritoneal cavity, as well as hyperimmune mouse serum, have been unsuccessful despite the fact that resistance to an intravenous challenge in immunized donors can be clearly demonstrated.
Since the use of various syngeneic and congenic strains of mice to investigate the immunological and genetic factors involved in determining resistance to various infectious agents has met with success in recent years, we began a search for mouse strains susceptible and resistant to C. albicans. By using such an approach, we would not have the disadvantages of models involving immunological manipulations wherein multiple and somewhat uncontrollable effects could influence the data derived from such work. We report here, therefore, our initial studies involving in vitro and in vivo responses IMMUNE RESPONSES TO C. ALBICANS 1021 to immunization via the cutaneous route as well as responses to intravenous challenge of both immune and naive animals in six genetically distinct strains of mice.
MATERIALS AND METHODS
Mice. Six-to eight-week-old male mice of the following strains were obtained from Jackson Laboratories, Bar Harbor, Maine: BALB/cByJ, C57BL/6J, DBA/2J, A/J, C3H/HeJ, and CBA/J. Outbred CD-1 mice were obtained from Charles River Farms, Wilmington, Mass. All mice were maintained under conventional conditions and fed mouse chow and water ad libitum.
Culture methods. C. albicans B311, originally obtained from H. Hasenclever, National Institutes of Health, was used throughout these studies. It was maintained at 4°C by monthly transfer on Sabouraud dextrose agar (Scott Laboratories, Inc., Fiskville, R.I.). Viable blastospores for inoculation into mice were grown in tryptic soy dialysate broth (35) for 18 h at 37°C on a gyratory shaker operating at approximately 165 rpm before harvesting by centrifugation. After three washes with sterile nonpyrogenic saline (NPS) (Cutter Laboratories, Inc., Berkeley, Calif.), the blastospores were counted in a hemacytometer and suspended in NPS at the desired concentration. Each suspension was further diluted and spread onto Sabouraud agar plates to determine the viable count. Viable blastospores from which antigens were prepared were inoculated in soy dialysate broth as above, but after harvest they were washed four times with phosphate-buffered saline (PBS) (0.15 M, pH 7.2) containing 0.001 M phenylmethylsulfonyl fluoride and stored at -20°C in the same buffer until fractionated.
Fractionation procedures and source of test antigens. Subcellular components were prepared from blastospores suspended in PBS-phenylmethylsulfonyl fluoride by disruption with ballistic action in a Braun homogenizer followed by differential centrifugation as described previously (7) . The two fractions used in this study are designated as B-HEX and SCS. The SCS, soluble cytoplasmic substances, was the dialyzed and lyophilized supernatant remaining after a final centrifugation at 144,000 x g for 2 h. B-HEX was prepared from a 'membrane-mitochondria fraction which had been extracted with butanol (28) and hot PBS (7) before the precipitation of protein with 100%o saturated ammonium sulfate. The precipitate was redissolved in and dialyzed against NPS and stored at -70°C. Protein content was determined by the method of Lowry et al. (21) , using bovine serum albumin as a standard.
Animal immunization and challenge. Mice were immunized as described previously (10) by two intracutaneous inoculations of 106 live C. albicans B311 blastospores suspended in 0.05 ml of NPS. When testing for a protective respon'se, control and immunized animals were challenged intravenously via the lateral tail vein with viable blastospores suspended to the appropriate concent,ration in 0.5 ml of NPS. Animals were monitored for mortality for 28 6.7 Ci/mmol; New England Nuclear Corp., Boston, Mass.) delivered in 10 IlI of NPS. Mitogens were harvested on the 4th day of incubation and antigens on the 5th day of incubation. After drying at 100°C for 20 min, the glass fiber disks were punched out into plastic liquid scintillation vials (New England Nuclear), and 10 ml of liquid scintillation solution containing 3.66 g of 2,5-diphenyoxazole (New England Nuclear) per liter of scintillation-grade toluene (J. T. Baker Chemical Co., Phillipsburg, N.J.) was added. Samples were counted in a Beckman LS250 for a minimum of 10 min or 10,000 counts, and results were expressed as the mean of the three samples in counts per minute.
Antibody detection. Anti-Candida antibody in the sera of infected mice was determined by a solid-phase, double antibody enzyme-linked immunosorbent assay. The method used was adapted from several published techniques; therefore, the procedure is described herein. SCS, the preparation used as the Candida-specific antigen, was dissolved in 0.05 M sodium carbonate buffer (pH 9.6) to achieve a protein concentration of 50 VOL. 38, 1982 on October 27, 2017 by guest http://iai.asm.org/ 1022 HECTOR, DOMER, AND CARROW ,ug/ml, and 200 p.l per well was added to 96-well polyvinyl microtiter plates (Dynatech Laboratories, Inc., Alexandria, Va.). The plates were incubated for 2 h at 37°C and then washed four times with 0.15 M PBS (pH 7.2) with 0.05% Tween 20. All wells were then coated with a solution of 1 mg of bovine serum albumin per ml (Sigma Chemical Co., St. Louis, Mo.) in carbonate buffer, 200 ,ul per well, and incubated and washed as before. Sera to be tested were serially diluted with PBS-Tween 20 supplemented with 1% fetal calf serum (M.A. Biologicals), starting with a 1:50 dilution followed by twofold dilutions to a final dilution of 1:6,400. A positive control, consisting of a pool of sera from immunized mice and a negative control from unimmunized mice, were diluted in like manner. A 150-,l portion of each serum dilution was placed in the appropriate well, with each plate containing at least one positive control series, and incubated overnight at 4°C. The plates were then washed as before, and 200 ,ul of a 1:800 dilution (optimal concentration determined by checkerboard titrations) of peroxidaselabeled affinity-purified goat anti-mouse immunoglobulin G and immunoglobulin M heavy and light chains (Kirkegaard and Perry Labs, Gaithersburg, Md.) in PBS with 1% fetal calf serum (no Tween 20) was then added to each well before incubation for 2 h at 37°C. A 200-p.l portion of the substrate for the enzyme system, which consisted of 0.01% hydrogen peroxide (Sigma) and 0.01% 2,2'-azino-di-[3-ethylbenzthiazoline sulfonate] (Sigma) in 0.1 M sodium citrate buffer (pH 4.0) prepared immediately before use, was added to each well, and the plates were incubated for 30 min at room temperature in the dark. The reaction was stopped by the addition of 50 ,ul of a solution of 10 parts 6 mM NaOH and 0.18% hydrofluoric acid and 1 part 0.4 M NaOH and 78 mM EDTA. The plates were allowed to sit for an additional 10 min before the optical density of the samples was measured at 417 nm. Values for representative positive control results were plotted as optical density versus log2 titer to determine the 50% endpoint value, and the corresponding optical density value was used to determine the titers of the samples.
Complement assay. A hemolytic complement assay was performed according to published methods (15, 45) . Briefly, ox erythrocytes were sensitized with rabbit anti-ox erythrocyte antibody, kindly supplied by W. K. Anderson, Tulane University, and suspended to a 2% solution. Sera to be analyzed were diluted with barbital buffer in twofold dilutions, starting with a 1:4 dilution. A 200-,ul portion of each dilution was dispensed, in duplicate, into glass tubes, and then 50 ,ul of the sensitized erythrocytes were added. The tubes were incubated at 37°C for 30 min, centrifuged at 400 x g for 10 min, and the supernatants read at 415 nm. The results were plotted, and the CH50 value was calculated as described (45) .
Calculations and statistical analyses. 
RESULTS
In vivo cellular immunity. To detect delayed hypersensitivity, mice from each strain were footpad tested with B-HEX 7 days after a second cutaneous inoculation of C. albicans, the time at which the response is known to be maximum for CBA/J mice (7). The results from two experiments are summarized in Fig. 1 three strains which had segregated into the highly reactive group in the previous two experiments.
In vitro cellular immunity. Lymph node cells from control mice or from mice infected twice cutaneously, the second inoculation having been 10 days before sacrifice, were stimulated with the mitogens LPS and PHA and with two antigen preparations derived from C. albicans, B-HEX and SCS. Ten days after the second cutaneous inoculation was selected because that is known to be the time of maximum response in CBA/J mice (7). The results of three experiments using the mitogens and antigens are summarized in Fig. 2 and 3 , respectively. Responses to LPS were minimal in all six strains, perhaps due to the low percentage of B-cells found in lymph nodes; but on a relative basis, the C57BL/6J cells were consistently more responsive than those from the other strains. Cells from strains BALB/cByJ, A/J, and C3H/HeJ were the least responsive to LPS. There were good, though variable, responses by all cells to PHA, with C57BL/6J and DBA/2J cells being the least responsive. Only cells from strains C3H/HeJ and CBA/J showed significant differences between the responses of control and infected animals. The lack of differences between control and infected cell responses in the majority of strains suggest there was no suppression in any of the cell cultures.
In contrast to the results obtained with the mitogens, the cell suspensions from immunized mice responded equally well to the Candida antigens, regardless of the mouse strain. Although the results of the individual experiments varied somewhat, when the data were pooled Susceptibility of mice to intravenous challenge. Two weeks after receiving a second immunizing inoculation of C. albicans blastospores, the time at which CBA/J mice are known to be resistant to challenge (10), immunized and control mice from each of the six strains were challenged intravenously with 4 x 103, 5 x 103, or 7.5 x 103 viable C. albicans blastospores in three separate experiments. The mortality results after 28 days of observation, together with the cultural data on kidneys and brains, are presented in Table 1 . Naive mice segregated into sensitive, intermediate, and resistant groups, with C57BL/6J and BALB/cByJ being highly resistant. The other four strains were more susceptible, with higher levels of colonization in the kidneys and some deaths occurring before the time of sacrifice. DBA/2J mice were the most susceptible, with greater than six log units of yeast in their kidneys and a high percentage of deaths occurring. In response to immunization, however, five of the six strains were able to limit multiplication in kidneys to a level two to three log units lower than that observed in unimmunized animals.
In contrast to the significant differences observed in colony counts among the kidney cultures when naive mice were challenged intrave- nously, there were few differences in the numbers of Candida recovered from brain. In most cases, however, there was a statistically significant difference between the levels of yeast seen in naive versus immunized mouse brains in each strain in the three experiments (Table 1) .
Antibody levels. At the time of sacrifice for cultures of kidneys and brains, blood was collected from each mouse for determinations of anti-Candida antibody by an enzyme-linked immunosorbent assay. The results of the three experiments are presented in Fig. 4 .
Although virtually all strains of mice which had been sensitized before challenge had high levels of circulating antibody to C. albicans, the unimmunized mice varied considerably in their production of antibody in response to intravenous infection. Mice from strains C57BL/6J and BALB/cByJ had essentially no detectable antibody at the end of the 28-day period of infection, whereas the other four strains were able to mount low to moderate responses. A pool of sera from cutaneously infected but not intravenously challenged CBAIJ mice was used as a positive control for the assay, and typically gave titers of 1:200. Not surprisingly, the process of intravenous infection boosted antibody production in immunized mice, as the mean titers for the immunized and challenged CBA/J mice were between 1:400 and 1:800. Because of the differences in the numbers of samples in the various groups, no meaningful statistical analyses were possible.
Complement assay. Simple hemolytic assays were performed on all strains of mice in this study to verify known deficiencies in the C5 component in strains DBA/2J and A/J (5). Although the assay as used was incapable of resolving concentration differences in each of the nine components of the classical pathway, it nonetheless offered indirect verification of the complement status of those two strains. An outbred CD-1 strain, which was assumed to have intact complement components, was included as a positive control, and the results were computed as CH50 U/ml (45) . The CD-1 mice had the highest levels of hemolytic activity, with 32.2 U/ml, and the six strains of inbred mice had moderate to negligible levels of hemolytic activity. As expected, the DBA/2J and A/J had essentially little or no demonstrable levels, with 0.0 and 3.2 U/ml, respectively. C3H/HeJ mice were also essentially negative, with a value of 0.2 U/ml. C57BL/6J and BALB/cByJ mice had moderate levels of activity, with 25.3 and 10.3 U/ml, respectively, and CBA/J mice had 6.5 U/ml. DISCUSSION Naive mice from the six strains of inbred mice used in this study showed substantial differences in susceptibility to C. albicans when challenged intravenously with the fungus. Based on the results of both the quantitative cultures of kidneys, the target organ in systemic candidiasis, and the mortality data, strains BALB/cByJ and C57BL/6J had a high degree of native resistance to challenge; strains A/J, C3H/HeJ, and CBA/J were moderately susceptible, and strain DBA/2J was highly susceptible. In an effort to determine the mechanisms which might be responsible for the observed differences, features of innate and acquired resistance were considered. The results of this study suggest a major role for complement in the innate resistance to C. albicans in the mouse model. The DBA/2J strain, in particular, and the A/J strain to a lesser extent, were found to be susceptible to systemic candidiasis, and both have been reported to be deficient in the C5 component of complement (5). Although we did not determine the levels of C5 specifically, both strains were deficient in hemolytic complement activity. Thus, our results confirm the in vivo studies of Morelli and Rosenberg (24) , who used outbred mice, and Gelfand et al. (9) , who used guinea pigs, in which animals lacking an intact alternative pathway of complement did not survive as long as animals with an intact complement system. In vitro studies, on the other hand, have either not satisfactorily confirmed the in vivo data or have resulted in conflicting data. Morelli and Rosenberg (25) , for example, reported in a second study that sera from C5 deficient mice did not support phagocytosis of the fungus in an in vitro phagocytic assay as well as sera from mice with C5. This effect, however, was only evident at certain periods during incubation, and not at others. In contrast to the latter study, it has recently been reported (27) that the sera from mouse strains DBA/2J and D1OD2/oSn, which are deficient in the C5 component, were able to opsonize and promote phagocytosis of C. albicans blastospores by mouse PMN in vitro on a level equal to that of serum from mice with normal levels of C5. Furthermore, through depletion of factor C3 from normal serum, they were able to demonstrate a reduction in phagocytosis of yeast and concluded that C3 was the primary opsonin of C. albicans for phagocytosis by PMN. Interestingly, it has been reported that mannan extracted from the cell walls of C. albicans is able to activate the alternative pathway of complement in human serum with a concomitant release of chemotactic factors (34) . Since it has been demonstrated that activated C5 but not C3 has chemotactic activity towards PMN in both in vitro and in vivo systems (8, 39) , it is tempting to speculate that the increased susceptibility to candidiasis seen in C5 deficient mice in our studies, as well as in those of Morelli and Rosenberg (26), may not have been due to VOL. 38, 1982 on October 27, 2017 by guest http://iai.asm.org/ the inability to opsonize and phagocytose the fungus, but rather to the inability to mount an adequate inflammatory response.
The role of PMN in defense against candidiasis is well known, its importance having been demonstrated in clinical studies in humans (18, 19, 41) as well as in studies with experimental animals (13, 30, 38) . Thus, in the infected animal, the ability to opsonize the organism as well as promote chemotaxis of PMN into regions of fungal invasion may be of equal importance, and the high levels of susceptibility seen in the DBA/2J mice, which might be deficient in the ability to induce chemotaxis, could be attributed to a lack of chemotactic activity. The increased susceptibility of DBA/2J mice does not appear to be related to the numbers of circulating PMN, since it has been reported in the literature (6) that that strain has relatively high levels of circulating PMN, whereas the more resistant strains have lower counts. Our own limited determinations (data not shown) confirmed the literature reports, in that the DBA/2J mice, the most susceptible strain, had over twice the number of circulating PMN as mice from strain C57BL/6J, a highly resistant strain.
Elucidation of the factors responsible for acquired immunity to candidiasis in inbred mice has proven to be somewhat difficult. All strains of mice used in this study were capable of developing some measure of resistance to intravenous challenge with C. albicans if they were immunized by the intracutaneous inoculation of viable cells before challenge. In fact, five of the six strains showed a reduction of two to three log units in the levels of colonization in the kidneys in immunized versus naive animals. That mice from strain BALB/cByJ did not show such reductions in two of the three experiments is not surprising in view of the already low levels of colonization in the naive animals. The results of the antibody assays in naive animals would seem to indicate that antibody played no role in native resistance and by inference, therefore, in acquired resistance. The two most resistant strains of mice, C57BL/6J and BALB/cByJ, had essentially no detectable levels of antibody at the end of the 28-day infection period when naive animals were challenged intravenously, whereas the more susceptible strains had demonstrable titers of antibody. Thus, the differences observed in antibody titers may simply be a case of differences in the antigen load, such that susceptible strains with their higher levels of colonization produced more antibody in response to the higher antigenic insult. It has been demonstrated previously that in in vitro phagocytosis assays, specific antibody plays little or no role in the phagocytosis and subsequent killing of C. albicans (16, 25, 27) .
If antibody does not play a role in acquired immunity, then perhaps one must postulate a protective role for cell-mediated immunity, as has been clearly demonstrated for coccidioidomycosis (2) . The results of the lymphocyte proliferation and footpad assays demonstrated clearly that all six strains were capable of mounting cell-mediated responses to antigens from C. albicans. Correlation of these T-cell responses with the ability to resist infection by cell-mediated immunity is more difficult, however. Although Hurtrel et al. (13) and Moser and Domer (28) reported a lack of correlation between delayed-type hypersensitivity and protection in systemic candidiasis, Kagaya et al. (17) felt the temporal relationship between acquisition of a delayed-type response and resistance to infection observed in their mouse model was good evidence for their correlation. Although our results suggest the relative importance of a cell-mediated versus a humoral response in acquired immunity to candidiasis, actual proof of the dominance of either aspect of the immune response would be dependent on cell transfer experiments. Attempts at transferring protection to naive mice against infection with C. albicans with either immune serum (17, 29, 32) or cells from immune donors (13, 23, 32, 40) have led to conflicting and less than convincing results.
There have been only a few publications in which the responses of various inbred strains of mice to fungal agents were reported. In the most recent, Bistoni et al. (3) reported strain differences in susceptibility to intravenous challenge with C. albicans slightly different than ours in that at certain doses, C3H/HeJ mice were as resistant to challenge as BALB/c mice. Their data are difficult to compare with ours, however, because the authors used much larger inocula and reported only the mean survival time as a basis for resistance. Earlier, resistance to Cryptococcus neoformans was found to be under single-gene control, with the gene product reputed to be C5 (36) . Finally, Morozumi et al. (26) reported wide variations in susceptibility of nine inbred strains of mice to Blastomyces dermatitidis given intranasally, but no obvious reasons for such differences were evident.
The use of inbred mice to study infectious agents other than fungi has been exploited with success. Interestingly, studies with parasitic (1, 20, 31, 44, 47) and bacterial agents (12, 33, 43) have shown that there are no uniform trends in the ability of selected strains of mice to resist all members of a given class of pathogen. Additionally, in most of the studies cited above, the determinants of resistance were reported to have no close linkage to the H-2 locus. This would appear to be the case with C. albicans, as BALB/cByJ and DBA/2J mice, representing the most resistant and susceptible mice in our study, respectively, share the same H-2 haplotype. Confirmation of the genetic restrictions in candidiasis will, however, require further studies.
